312 related articles for article (PubMed ID: 7863885)
1. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
2. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
[TBL] [Abstract][Full Text] [Related]
3. Value of chemical shift subtraction MRI in characterization of adrenal masses.
Savci G; Yazici Z; Sahin N; Akgöz S; Tuncel E
AJR Am J Roentgenol; 2006 Jan; 186(1):130-5. PubMed ID: 16357391
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
5. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
[TBL] [Abstract][Full Text] [Related]
6. MR evaluation of adrenal masses at 1.5 T.
Baker ME; Blinder R; Spritzer C; Leight GS; Herfkens RJ; Dunnick NR
AJR Am J Roentgenol; 1989 Aug; 153(2):307-12. PubMed ID: 2750617
[TBL] [Abstract][Full Text] [Related]
7. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation.
Fujiyoshi F; Nakajo M; Fukukura Y; Tsuchimochi S
AJR Am J Roentgenol; 2003 Jun; 180(6):1649-57. PubMed ID: 12760936
[TBL] [Abstract][Full Text] [Related]
8. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
10. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
[TBL] [Abstract][Full Text] [Related]
12. Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3 T--preliminary results.
Marin D; Soher BJ; Dale BM; Boll DT; Youngblood RS; Merkle EM
Radiology; 2010 Jan; 254(1):179-87. PubMed ID: 20032151
[TBL] [Abstract][Full Text] [Related]
13. Characterization of adrenal masses using MR imaging with histopathologic correlation.
Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
[TBL] [Abstract][Full Text] [Related]
14. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
Park BK; Kim CK; Kim B; Lee JH
Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
[TBL] [Abstract][Full Text] [Related]
15. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
[TBL] [Abstract][Full Text] [Related]
16. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of the adrenal gland.
Boland GW; Lee MJ
Crit Rev Diagn Imaging; 1995; 36(2):115-74. PubMed ID: 7612177
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of adrenal masses with MR imaging: comparison of techniques.
Reinig JW; Stutley JE; Leonhardt CM; Spicer KM; Margolis M; Caldwell CB
Radiology; 1994 Jul; 192(1):41-6. PubMed ID: 8208962
[TBL] [Abstract][Full Text] [Related]
19. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging.
Outwater EK; Siegelman ES; Radecki PD; Piccoli CW; Mitchell DG
AJR Am J Roentgenol; 1995 Sep; 165(3):579-83. PubMed ID: 7645474
[TBL] [Abstract][Full Text] [Related]
20. Adrenal masses: characterization with T1-weighted MR imaging.
Chezmar JL; Robbins SM; Nelson RC; Steinberg HV; Torres WE; Bernardino ME
Radiology; 1988 Feb; 166(2):357-9. PubMed ID: 3336711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]